JPM | Jpmorgan Chase & Co

CUSIP: 46625H100

7 Funds Holding

119K Total Shares

$39M Total Value

$354.22
Price

$941.6B

Market Cap

15.2

P/E Ratio

14.2

Forward P/E

$23.35

EPS (TTM)

1.68%

Dividend Yield

$1526.4B

Cash

$500.0B

Total Debt

2.66B

Shares Out

$279.10

$366.50

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Giverny Capital\|Francois Rochon	47.9K	$16M	0.53%	—	—
Patient Capital Management\|Samantha McLemore	29.4K	$10M	0.32%	—	—
Gardner Russo & Quinn\|Thomas Russo	24.7K	$8M	0.09%	—	—
Oakmark Select Fund\|Bill Nygren	6.2K	$2M	0.00%	—	—
Brave Warrior Advisors\|Glenn Greenberg	5.6K	$2M	0.04%	—	—
Kahn Brothers Group\|Thomas Kahn	2.9K	$942055	0.15%	$272.70	+33.06%
Greenhaven Associates\|Edgar Wachenheim III	2.5K	$818325	0.01%	—	—

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2026-Q2
Gardner Russo & Quinn	SELL	-83.4%	24.7K	$8M	$309.87
Giverny Capital	SELL	-8.5%	47.9K	$16M	$309.87
Patient Capital Management	SELL	-0.0%	29.4K	$10M	$309.87
Greenhaven Associates	SELL	-37.5%	2.5K	$818325	$309.87
Kahn Brothers Group	BUY	+2.1%	2.9K	$942055	$309.87
2026-Q1
Gardner Russo & Quinn	SELL	-71.9%	148.8K	$44M	$302.60
Giverny Capital	BUY	+0.9%	52.3K	$15M	$302.60
Patient Capital Management	SELL	-0.1%	29.4K	$9M	$302.60
Kahn Brothers Group	SELL	-18.7%	2.8K	$828942	$302.60
Saber Capital Management	SELL	EXIT	—	—	$302.60
2025-Q4
Gardner Russo & Quinn	SELL	-3.0%	528.8K	$170M	$309.25
Giverny Capital	BUY	+2.2%	51.8K	$17M	$309.25
Saber Capital Management	SELL	-93.8%	2.0K	$646373	$309.25
Kahn Brothers Group	BUY	+30.0%	3.5K	$1M	$309.25
2025-Q3
Gardner Russo & Quinn	SELL	-5.0%	545.0K	$172M	$294.90
Giverny Capital	SELL	-0.5%	50.7K	$16M	$294.90
Patient Capital Management	SELL	-0.0%	29.4K	$9M	$294.90
Greenhaven Associates	SELL	-20.0%	4.0K	$1M	$294.90
Kahn Brothers Group	SELL	-3.9%	2.7K	$841567	$294.90
2025-Q2
Gardner Russo & Quinn	SELL	-45.0%	573.7K	$166M	$260.71
Giverny Capital	BUY	+14.5%	51.0K	$15M	$260.71
Kahn Brothers Group	BUY	NEW	2.8K	$804500	$260.71
Kahn Brothers Group	SELL	EXIT	—	—	$260.71
2025-Q1
Gardner Russo & Quinn	SELL	-17.3%	1.0M	$256M	$257.40
Giverny Capital	BUY	+1.4%	44.5K	$11M	$257.40
Patient Capital Management	SELL	-0.0%	29.4K	$7M	$257.40
Kahn Brothers Group	SELL	-2.9%	2.9K	$703000	$257.40
2024-Q4
Gardner Russo & Quinn	SELL	-12.4%	1.3M	$302M	$238.36
Giverny Capital	BUY	+1.2%	43.9K	$11M	$238.36
2024-Q3
Gardner Russo & Quinn	SELL	-3.5%	1.4M	$304M	$210.19
Patient Capital Management	SELL	-81.2%	29.4K	$6M	$210.19
Giverny Capital	BUY	+7.7%	43.3K	$9M	$210.19
Greenhaven Associates	SELL	-33.3%	5.0K	$1M	$210.19
Kahn Brothers Group	SELL	-12.1%	3.0K	$622000	$210.19
2024-Q2
Greenhaven Associates	SELL	-99.8%	7.5K	$2M	$197.00
Gardner Russo & Quinn	SELL	-12.7%	1.5M	$302M	$197.00
Brave Warrior Advisors	SELL	-99.6%	5.6K	$1M	$197.00
Patient Capital Management	SELL	-28.0%	156.0K	$32M	$197.00
Giverny Capital	BUY	+2.6%	40.2K	$8M	$197.00
Kahn Brothers Group	SELL	-13.2%	3.4K	$679000	$197.00
2024-Q1
Greenhaven Associates	SELL	-2.1%	4.6M	$927M	$176.27
Gardner Russo & Quinn	SELL	-15.5%	1.7M	$343M	$176.27
Brave Warrior Advisors	SELL	-21.6%	1.3M	$260M	$176.27
Patient Capital Management	SELL	-19.3%	216.7K	$43M	$176.27
Giverny Capital	BUY	+6.6%	39.2K	$8M	$176.27
Kahn Brothers Group	SELL	-33.0%	3.9K	$775000	$176.27
2023-Q4
Greenhaven Associates	BUY	+0.1%	4.7M	$803M	$148.44
Gardner Russo & Quinn	SELL	-3.6%	2.0M	$344M	$148.44
Brave Warrior Advisors	SELL	-0.4%	1.7M	$282M	$148.44
Patient Capital Management	SELL	-12.6%	268.4K	$46M	$148.44
Giverny Capital	BUY	+0.5%	36.8K	$6M	$148.44
Gates Foundation Trust	SELL	EXIT	—	—	$148.44
Kahn Brothers Group	SELL	-0.0%	5.8K	$982000	$148.44
2023-Q3
Greenhaven Associates	SELL	-1.8%	4.7M	$684M	$148.76
Gardner Russo & Quinn	SELL	-0.7%	2.1M	$304M	$148.76
Brave Warrior Advisors	SELL	-1.4%	1.7M	$241M	$148.76
Patient Capital Management	SELL	-0.0%	307.1K	$45M	$148.76
Giverny Capital	BUY	+7.4%	36.6K	$5M	$148.76
Saber Capital Management	BUY	+0.8%	32.4K	$5M	$148.76
Gates Foundation Trust	BUY	NEW	29.6K	$4M	$148.76
Kahn Brothers Group	BUY	+2.0%	5.8K	$837000	$148.76
2023-Q2
Greenhaven Associates	BUY	+1.4%	4.8M	$699M	$138.45
Gardner Russo & Quinn	BUY	+16.2%	2.1M	$307M	$138.45
Brave Warrior Advisors	SELL	-0.6%	1.7M	$245M	$138.45
Patient Capital Management	BUY	+658.4%	307.2K	$45M	$138.45
Miller Value Partners	SELL	EXIT	—	—	$138.45
Giverny Capital	BUY	+9.1%	34.1K	$5M	$138.45
Saber Capital Management	SELL	-0.1%	32.1K	$5M	$138.45
2023-Q1
Greenhaven Associates	SELL	-1.2%	4.7M	$618M	$138.94
Gardner Russo & Quinn	SELL	-1.4%	1.8M	$237M	$138.94
Brave Warrior Advisors	SELL	-0.7%	1.7M	$221M	$138.94
Miller Value Partners	SELL	-22.7%	269.9K	$35M	$138.94
Saber Capital Management	SELL	-40.8%	32.2K	$4M	$138.94
Patient Capital Management	SELL	-11.0%	40.5K	$5M	$138.94
Kahn Brothers Group	BUY	+36.0%	3.8K	$492000	$138.94
2022-Q4
Greenhaven Associates	SELL	-0.5%	4.8M	$643M	$131.28
Gardner Russo & Quinn	SELL	-4.4%	1.8M	$247M	$131.28
Brave Warrior Advisors	SELL	-1.5%	1.7M	$229M	$131.28
Miller Value Partners	SELL	-10.9%	349.2K	$47M	$131.28
Saber Capital Management	BUY	+0.2%	54.3K	$7M	$131.28
Patient Capital Management	BUY	+2.4%	45.5K	$6M	$131.28
Giverny Capital	BUY	+9.5%	31.2K	$4M	$131.28
Chou Associates Management	SELL	EXIT	—	—	$131.28
2022-Q3
Greenhaven Associates	BUY	+6.3%	4.8M	$504M	$114.67
Gardner Russo & Quinn	SELL	-1.3%	1.9M	$202M	$114.67
Brave Warrior Advisors	SELL	-0.1%	1.7M	$181M	$114.67
Miller Value Partners	BUY	+0.5%	391.8K	$41M	$114.67
Giverny Capital	SELL	-90.0%	28.5K	$3M	$114.67
Saber Capital Management	BUY	NEW	54.2K	$6M	$114.67
Patient Capital Management	BUY	+10.8%	44.5K	$5M	$114.67
Kahn Brothers Group	SELL	-1.8%	2.8K	$290000	$114.67
2022-Q2
Greenhaven Associates	BUY	+600.7%	4.5M	$511M	$123.92
Gardner Russo & Quinn	SELL	-8.4%	2.0M	$220M	$123.92
Brave Warrior Advisors	BUY	+9.0%	1.7M	$196M	$123.92
Miller Value Partners	SELL	-1.1%	389.8K	$44M	$123.92
Giverny Capital	BUY	+2.8%	284.2K	$32M	$123.92
Patient Capital Management	BUY	+11.1%	40.1K	$5M	$123.92
Kahn Brothers Group	SELL	-10.3%	2.8K	$318000	$123.92
2022-Q1
Gardner Russo & Quinn	SELL	-9.0%	2.1M	$291M	$147.92
Brave Warrior Advisors	BUY	+6.6%	1.6M	$217M	$147.92
Greenhaven Associates	BUY	NEW	647.0K	$88M	$147.92
Miller Value Partners	SELL	-2.7%	394.2K	$54M	$147.92
Giverny Capital	BUY	+3.5%	276.5K	$38M	$147.92
Patient Capital Management	SELL	-9.5%	36.1K	$5M	$147.92
Chou Associates Management	SELL	-29.2%	24.3K	$3M	$147.92
2021-Q4
Gardner Russo & Quinn	SELL	-6.8%	2.3M	$371M	$165.36
Brave Warrior Advisors	SELL	-10.6%	1.5M	$237M	$165.36
Miller Value Partners	SELL	-10.3%	405.2K	$64M	$165.36
Giverny Capital	SELL	-30.0%	267.3K	$42M	$165.36
Kahn Brothers Group	SELL	-10.6%	3.1K	$498803	$165.36
2021-Q3
Gardner Russo & Quinn	SELL	-9.8%	2.5M	$412M	$157.07
Brave Warrior Advisors	SELL	-9.5%	1.7M	$274M	$157.07
Miller Value Partners	SELL	-0.5%	452.0K	$74M	$157.07
Giverny Capital	BUY	+5.0%	381.8K	$62M	$157.07
2021-Q2
Gardner Russo & Quinn	SELL	-9.5%	2.8M	$434M	$155.72
Brave Warrior Advisors	SELL	-15.3%	1.8M	$287M	$155.72
Miller Value Partners	BUY	+1.3%	454.1K	$71M	$155.72
Giverny Capital	BUY	+2.6%	363.5K	$57M	$155.72
Kahn Brothers Group	BUY	+74.1%	3.5K	$548279	$155.72
2021-Q1
Gardner Russo & Quinn	SELL	-14.2%	3.1M	$469M	$144.88
Brave Warrior Advisors	SELL	-2.1%	2.2M	$332M	$144.88
Miller Value Partners	SELL	-0.1%	448.1K	$68M	$144.88
Giverny Capital	BUY	+2.5%	354.4K	$54M	$144.88
Hillman Capital Management	SELL	EXIT	—	—	$144.88
2020-Q4
Gardner Russo & Quinn	SELL	-4.9%	3.6M	$456M	$115.25
Brave Warrior Advisors	SELL	-0.7%	2.2M	$283M	$115.25
Berkshire Hathaway	SELL	EXIT	—	—	$115.25
Miller Value Partners	BUY	+13.6%	448.5K	$57M	$115.25
Giverny Capital	BUY	+2.7%	345.6K	$44M	$115.25
Hillman Capital Management	BUY	+20.9%	38.1K	$5M	$115.25
Kahn Brothers Group	SELL	-43.5%	2.0K	$257317	$115.25
2020-Q3
Berkshire Hathaway	SELL	-95.6%	967.3K	$93M	$98.55
Gardner Russo & Quinn	BUY	+4.3%	3.8M	$364M	$98.55
Brave Warrior Advisors	BUY	+12.8%	2.2M	$216M	$98.55
Miller Value Partners	SELL	-0.7%	394.9K	$38M	$98.55
Giverny Capital	BUY	+1.3%	336.5K	$32M	$98.55
Omega Advisors	SELL	EXIT	—	—	$98.55
Greenhaven Associates	SELL	-97.8%	5.0K	$481000	$98.55
Kahn Brothers Group	SELL	-7.9%	3.6K	$344742	$98.55
2020-Q2
Berkshire Hathaway	SELL	-61.5%	22.2M	$2.1B	$94.46
Gardner Russo & Quinn	SELL	-5.6%	3.6M	$340M	$94.46
Brave Warrior Advisors	BUY	+4.3%	2.0M	$187M	$94.46
Greenhaven Associates	SELL	-50.8%	228.7K	$22M	$94.46
Miller Value Partners	SELL	-0.2%	397.7K	$37M	$94.46
Giverny Capital	BUY	+2.9%	332.1K	$31M	$94.46
Omega Advisors	BUY	+72.2%	310.0K	$29M	$94.46
Hillman Capital Management	BUY	NEW	31.5K	$3M	$94.46
Kahn Brothers Group	SELL	-1.2%	3.9K	$365705	$94.46
2020-Q1
Berkshire Hathaway	SELL	-3.0%	57.7M	$5.2B	$134.23
Gardner Russo & Quinn	BUY	NEW	3.8M	$345M	$134.23
Brave Warrior Advisors	BUY	+3.8%	1.9M	$172M	$134.23
Miller Value Partners	SELL	-26.2%	398.3K	$36M	$134.23
Giverny Capital	SELL	-5.1%	322.7K	$29M	$134.23
Greenhaven Associates	BUY	NEW	465.1K	$42M	$134.23
Omega Advisors	BUY	NEW	180.0K	$16M	$134.23
Chou Associates Management	SELL	-22.6%	34.3K	$3M	$134.23
Kahn Brothers Group	BUY	NEW	3.9K	$354268	$134.23
Sequoia Fund	SELL	EXIT	—	—	$134.23
Hillman Capital Management	SELL	EXIT	—	—	$134.23
2019-Q4
Brave Warrior Advisors	SELL	-9.2%	1.8M	$256M	$129.63
Greenhaven Associates	SELL	-99.8%	5.0K	$697000	$129.63
Miller Value Partners	SELL	-17.0%	539.5K	$75M	$129.63
Giverny Capital	BUY	+0.7%	340.0K	$47M	$129.63
Gardner Russo & Quinn	BUY	+0.6%	10.4K	$1M	$129.63
2019-Q3
Greenhaven Associates	SELL	-57.7%	2.1M	$244M	$113.54
Brave Warrior Advisors	SELL	-0.6%	2.0M	$239M	$113.54
Miller Value Partners	SELL	-8.0%	649.9K	$76M	$113.54
Giverny Capital	BUY	+1.1%	337.8K	$40M	$113.54
Chou Associates Management	SELL	-59.5%	44.3K	$5M	$113.54
Gardner Russo & Quinn	SELL	-15.1%	10.3K	$1M	$113.54
Sequoia Fund	BUY	NEW	1.7K	$201000	$113.54
2019-Q2
Greenhaven Associates	SELL	-1.4%	4.9M	$548M	$110.13
Brave Warrior Advisors	SELL	-1.4%	2.0M	$228M	$110.13
Miller Value Partners	SELL	-8.0%	706.0K	$79M	$110.13
Giverny Capital	BUY	+5.0%	334.0K	$37M	$110.13
Gardner Russo & Quinn	BUY	+0.6%	12.1K	$1M	$110.13
2019-Q1
Berkshire Hathaway	BUY	+18.8%	59.5M	$6.0B	$103.39
Greenhaven Associates	SELL	-1.6%	5.0M	$503M	$103.39
Brave Warrior Advisors	BUY	+6.9%	2.1M	$209M	$103.39
Miller Value Partners	SELL	-0.4%	767.4K	$78M	$103.39
Giverny Capital	BUY	+5.3%	318.1K	$32M	$103.39
Gardner Russo & Quinn	BUY	+0.6%	12.1K	$1M	$103.39
2018-Q4
Berkshire Hathaway	BUY	+40.5%	50.1M	$4.9B	$108.11
Greenhaven Associates	SELL	-3.1%	5.1M	$493M	$108.11
Brave Warrior Advisors	BUY	+8.1%	1.9M	$189M	$108.11
Miller Value Partners	BUY	+0.1%	770.7K	$75M	$108.11
Giverny Capital	BUY	+46.1%	302.2K	$30M	$108.11
Gardner Russo & Quinn	BUY	+4.2%	12.0K	$1M	$108.11
2018-Q3
Berkshire Hathaway	BUY	NEW	35.7M	$4.0B	$114.62
Greenhaven Associates	SELL	-2.3%	5.2M	$588M	$114.62
Brave Warrior Advisors	BUY	+0.2%	1.8M	$202M	$114.62
Miller Value Partners	BUY	NEW	770.3K	$87M	$114.62
Miller Value Partners	SELL	EXIT	—	—	$114.62
Sequoia Fund	SELL	EXIT	—	—	$114.62
Giverny Capital	BUY	NEW	206.8K	$23M	$114.62
Chou Associates Management	BUY	NEW	109.3K	$12M	$114.62
Chou Associates Management	SELL	EXIT	—	—	$114.62
Gardner Russo & Quinn	BUY	+476.0%	11.5K	$1M	$114.62
Gardner Russo & Quinn	SELL	EXIT	—	—	$114.62
2018-Q2
Greenhaven Associates	SELL	-20.0%	5.3M	$556M	$110.14
Brave Warrior Advisors	BUY	+19.9%	1.8M	$186M	$110.14
Miller Value Partners	SELL	-1.7%	1.2M	$76M	$110.14
Gardner Russo & Quinn	SELL	-50.8%	14.9K	$946000	$110.14
2018-Q1
Greenhaven Associates	SELL	-2.7%	6.7M	$734M	$114.33
Brave Warrior Advisors	SELL	-17.7%	1.5M	$164M	$114.33
Miller Value Partners	SELL	-1.9%	1.2M	$85M	$114.33
Gardner Russo & Quinn	SELL	-47.6%	30.3K	$2M	$114.33

No Insider Transactions

No Form 4 filings found for this stock in the last 2 years.